Zevra Therapeutics
ZVRA
ZVRA
69 hedge funds and large institutions have $41.8M invested in Zevra Therapeutics in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 14 increasing their positions, 24 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
32% less call options, than puts
Call options by funds: $6.34M | Put options by funds: $9.32M
38% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 8
42% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 24
Holders
69
Holding in Top 10
2
Calls
$6.34M
Puts
$9.32M
Top Buyers
| 1 | +$499K | |
| 2 | +$183K | |
| 3 | +$143K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$108K |
| 5 |
RPCONE
Retirement Planning Company of New England
Warwick,
Rhode Island
|
+$92.9K |
Top Sellers
| 1 | -$1.07M | |
| 2 | -$479K | |
| 3 | -$338K | |
| 4 |
Goldman Sachs
New York
|
-$317K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$286K |